Clonal haematopoiesis and risk of chronic liver disease.

Across large population cohorts, clonal haematopoiesis of indeterminate potential was linked to higher risk of chronic liver disease, including NASH. Specifically, LiverMultiScan findings in UK Biobank participants revealed a higher prevalence of liver disease activity and liver fat in individuals with CHIP. LiverMultiScan may represent a modifiable risk factor for e.g. blood cancers and cardiovascular disease.